Melanoma, Uveal
1 competing product in clinical development for Melanoma, Uveal.
Pipeline by Phase
Phase 21
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Pembrolizumab + Lenvatinib | Eisai | Phase 2 | Active | 39 |
1 competing product in clinical development for Melanoma, Uveal.
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Pembrolizumab + Lenvatinib | Eisai | Phase 2 | Active | 39 |